Evidence map›Paper›PMID 42676741›Full record

ArticleCentral-European journal of immunology2026

The AGO2-ATOX1 axis exacerbates inflammation in a mouse sepsis model.

Peng Huang, Meiling He, Xiangyang Mo, Lipu Deng

Abstract read
In one paragraph

Article in Central-European journal of immunology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Peng HuangDepartment of Emergency Medicine, The Affiliated Nanhua Hospital, Hengyang Medical School, University of South China, Hengyang 421002, Hunan, China.
Meiling HeDepartment of Laboratory Medicine, Hengyang First People's Hospital, Hengyang 421002, Hunan, China.
Xiangyang MoDepartment of Emergency Medicine, The Affiliated Nanhua Hospital, Hengyang Medical School, University of South China, Hengyang 421002, Hunan, China.
Lipu DengDepartment of Emergency Medicine, The Affiliated Nanhua Hospital, Hengyang Medical School, University of South China, Hengyang 421002, Hunan, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Introduction: The study aimed to investigate the mechanism of the Argonaute RISC catalytic component 2 (AGO2)-antioxidant protein 1 (ATOX1) axis in the inflammatory response of sepsis. Material and methods: AGO2 was knocked down by tail vein injection of sh-Ago2 lentivirus, and a sepsis mouse model was established using the cecal ligation and puncture (CLP) method. RAW264.7 cells were transfected with AGO2 or ATOX1 knockdown or overexpression plasmids and treated with lipopolysaccharide (LPS) to construct a cellular sepsis model. Hematoxylin-eosin staining was used to evaluate lung and liver tissue damage in mice. Serum levels of aspartate aminotransferase (AST) and alanine aminotransferase (ALT) were measured using biochemical analysis. ELISA was performed to determine the levels of inflammatory cytokines: tumor necrosis factor Results: AGO2 and ATOX1 were highly expressed in septic mice. In vitro experiments demonstrated that knockdown of AGO2 or ATOX1 suppressed LPS-induced inflammatory responses and macrophage polarization imbalance. AGO2 promoted M1 macrophage polarization and aggravated inflammatory damage by enhancing the stability of ATOX1 mRNA. In vivo experiments further confirmed that AGO2 knockdown significantly alleviated sepsis-induced lung and liver damage, reduced the inflammatory response, and inhibited ATOX1 expression. Conclusions: AGO2 binds to ATOX1 mRNA, promoting ATOX1 expression, inducing macrophage polarization imbalance, and exacerbating sepsis-induced inflammatory responses.

Indexed as

AGO2ATOX1inflammatory responsemacrophage polarizationsepsis

Identifiers

PMID42676741
PMCPMC13527614

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.